Amid tough competition, Novartis makes case for rheumatology drug Cosentyx
Swiss pharma hopes to bounce back from Q1 sales disappointment
Swiss pharma hopes to bounce back from Q1 sales disappointment
R-Pharm has a mid-stage rival.
But attendees warned to expect “oceanic” weather.